TRACK C - Biopharmaceuticals & Drugs:
Health Economics - Driving Value
Carefully targeted reimbursement and market access strategies are the key to successfully launching new products in today’s cost-conscious healthcare environment. Hear from three experts representing a broad range of life sciences subsectors, biopharma, medical device, and academia/consulting, as they explore how and where health economics data can be used in measuring value and delivering outcomes. Come away from this session with a better understanding how you can demonstrate your products’ value to patients, physicians, caregivers, payers, and policy makers. This will be an interactive session where attendees are encouraged to engage and ask questions.
President, TAMM Net
Mr. Spalding has over 25 years’ experience in pharmaceuticals and medical devices directing various functions including: reimbursement, clinical trial design and facility recruitment, distribution, business development, managed markets, market research, hospital sales, forecasting, and sales operations. Mr. Spalding held management and director level positions at various companies including Parke-Davis, Pfizer, Solvay, Peer-Point Medical Education, and Columbia Laboratories. In 2009, Mr. Spalding started TAMM Net, Inc., a consultancy servicing biomedical manufacturers. TAMM Net has helped manufacturers: conduct clinical trials; gain reimbursement; gain marketing approvals/clearances; and sell to federal purchasers. Mr. Spalding holds a B.S. in Chemistry from Union College, Schenectady, NY and an MBA in Health Administration from Temple University in Philadelphia.
Eddie Lee, PharmD
Head, U.S. Health Economics and Outcomes Research Strategy, UCB
Eddie Lee is the Head of Health Economics and Outcomes Research (HEOR) Strategy for UCB and is responsible for leading the development and execution of HEOR strategies to support both patient and access needs. He also leads a national team of medical outcomes liaisons that engages directly with decision-makers across all healthcare settings to inform them of UCB’s clinical and economic value propositions.
His areas of expertise include use of administrative claims databases, registries, and electronic medical records to develop resources aimed at improving informed decisions. He also represents the company’s vision and aspiration across engagements related to value assessment frameworks and more formal comparative effectiveness analyses.
Prior to his role at UCB, Eddie held roles leading the generation of real-world payer evidence across several disease states including diabetes, cardiovascular, anti-fungal therapy, and vaccines. He has also successfully executed research collaborations with several large integrated delivery networks and medical groups.
Eddie graduated from the University of Illinois at Chicago College of Pharmacy with a Doctorate of Pharmacy and completed a post-doctoral fellowship in health economics and outcomes research with Thomas Jefferson University in Philadelphia.
Harish Parihar, PhD
Assistant Dean for Assessment and Program Quality, Philadelphia College of Osteopathic Medicine (PCOM); Associate Professor of Pharmacy Practice, School of Pharmacy (SOP)
Dr. Parihar earned a BS in Pharmacy from the Institute of Chemical Technology (formerly UDCT) at Mumbai University and earned a PhD in Pharmaceutical Sciences from the University of Louisiana at Monroe in Monroe, LA. He completed his post-doctoral fellowship from the University of Kansas in Lawrence, KS. Dr. Parihar is a registered pharmacist in Georgia.
Currently, Dr. Parihar is an Assistant Dean for Assessment and Program Quality and Associate Professor of Pharmacy Practice at the Philadelphia College of Osteopathic Medicine (PCOM) School of Pharmacy in Suwanee, GA. In the past, Dr. Parihar has also held faculty positions at Lake Erie College of Osteopathic Medicine (LECOM) School of Pharmacy in Erie, Pennsylvania and Long Island University School of Pharmacy in Brooklyn, New York. Dr. Parihar is also a consultant Director of Health Economics at TAMM NET Inc.
Dr. Parihar has strong interest in clinical research, especially in the area of diabetes, cardiovascular disease, CNS, chronic pain. His research interests include:
Medication use and adherence patterns.
Cost-benefit, cost effectiveness and budget impact analysis of medication use.
Health outcomes, database analysis, systematic reviews and meta-analysis.
Global VP Health Economics & Reimbursement, Avanos Medical
Anne Stefurak is the Global Vice President of Health Economics and Reimbursement for Avanos Medical, Inc. Headquartered in Alpharetta, Georgia, Avanos is a global medical device company focused on acute and interventional pain management devices as well as digestive and respiratory products. Anne has eighteen (18) years experience in medical device and biotech reimbursement, ten (10) years in commercial payer health policy and contracting as well as hospital and practice administration. She is also an intensive care and coronary care registered nurse with certifications in professional and hospital outpatient coding. She has held multiple high level executive positions in various companies responsible for market access and economic strategy for minimally invasive and implantable technologies, medical supplies, capital and durable medical equipment as well as biologics. She has spoken on the evolving role of reimbursement in the Life Science industry in multiple venues.